Thursday, November 14, 2013

AWHONN Webinar: New Research & Strategies for Supporting Breastfeeding

"Register today and you and your colleagues will gain cutting edge knowledge about:

Recognizing recent trends in breastfeeding, including how breastfeeding is becoming the global norm.

New evidence about the dose-dependentnature of breastfeeding benefits; that many of the short-and long-term maternal and infant health benefits of breastfeeding are even better with longer breastfeeding duration.

How implementing BabyFriendly principles improves breastfeeding outcomes even ifyour facility does not have this designation.

Implementing evidence-based strategies to facilitate and support optimal breastfeeding outcomes throughout the childbearing continuum.

Evidence-based practice resources that promote breastfeeding."

Aluminium Content in Infant Formulas


Sunday, September 08, 2013

What are the rules for employers of pumping moms?

Nursing Mothers Card

The graphic links to the info in a convenient card format.

More detailed information from the Department of Labor Wage and Hour Division here:

Friday, August 30, 2013

Midwives Improve Outcomes, Says Cochrane Review

Increased PPH with antidepressants

Friday, August 02, 2013

Breastfeeding rates up states CDC

Great news!

Maternal Pulse Pressure Predicts Fetal Heart Rate Changes After Epidural Anesthesia

Another study finds higher IQ in breastfed children

"We found that longer duration of breastfeeding and greater exclusivity of breastfeeding were associated with better receptive language at age 3 years and with higher verbal and nonverbal IQ at age 7 years"

...and yes, they corrected for social conditions that can affect the results...

ACOG launches initiative to improve breastfeeding rates

Wednesday, June 19, 2013

Scans show breastmilk good for brain

Monday, May 06, 2013

FDA Warns Against Valproate to Prevent Migraine in Pregnancy "The US Food and Drug Administration (FDA) has strengthened warnings against the use of valproate products as a preventive measure against migraine in women who are pregnant. The new contraindication is based on recently published data from the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study showing further evidence that exposure to valproate products during pregnancy can lead to reduced IQ scores in children. "Valproate medications should never be used in pregnant women for the prevention of migraine headaches because we have even more data now that show the risks to the children outweigh any treatment benefits for this use," Russell Katz, MD, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research in a statement today. Valproate products include valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor) and their generic forms. These medications already carry a boxed warning for fetal risk, including birth defects, but the new data from NEAD, published online in Lancet Neurology and reported by Medscape Medical News at that time, has led to today's strengthened warning."